ArticleEClinicalMedicine2023

COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2.

Alex J Szubert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.